Nantahala Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Nantahala Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-596,666	Closed	-$5.95M	–	164
2025 Q2	$5.95M	Buy	+596,666	New	+$4.81M	0.23%	82

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nantahala Capital Management's ITOS Position: Q3 2025 in Review

Nantahala Capital Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 596,666 shares — an estimated $5.95M sold.

Nantahala Capital Management first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $5.95M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Nantahala Capital Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Nantahala Capital Management sold 596,666 iTeos Therapeutics shares in Q3 2025, an estimated $5.95M.
Nantahala Capital Management first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Nantahala Capital Management's iTeos Therapeutics position peaked at $5.95M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Nantahala Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.